Literature DB >> 28504270

Antiplatelet therapy: New score for predicting bleeding risk after DAPT.

Bastiaan Zwart1, Jurriën M Ten Berg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28504270     DOI： 10.1038/nrcardio.2017.71

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.

Authors:  Philippe Généreux; Gennaro Giustino; Bernhard Witzenbichler; Giora Weisz; Thomas D Stuckey; Michael J Rinaldi; Franz-Josef Neumann; D Christopher Metzger; Timothy D Henry; David A Cox; Peter L Duffy; Ernest Mazzaferri; Mayank Yadav; Dominic P Francese; Tullio Palmerini; Ajay J Kirtane; Claire Litherland; Roxana Mehran; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2015-09-01       Impact factor: 24.094

Review 3.  Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Authors:  Francesco Costa; David van Klaveren; Stefan James; Dik Heg; Lorenz Räber; Fausto Feres; Thomas Pilgrim; Myeong-Ki Hong; Hyo-Soo Kim; Antonio Colombo; Philippe Gabriel Steg; Thomas Zanchin; Tullio Palmerini; Lars Wallentin; Deepak L Bhatt; Gregg W Stone; Stephan Windecker; Ewout W Steyerberg; Marco Valgimigli
Journal:  Lancet       Date:  2017-03-11       Impact factor: 79.321

4.  Long-term use of ticagrelor in patients with prior myocardial infarction.

Authors:  Marc P Bonaca; Deepak L Bhatt; Marc Cohen; Philippe Gabriel Steg; Robert F Storey; Eva C Jensen; Giulia Magnani; Sameer Bansilal; M Polly Fish; Kyungah Im; Olof Bengtsson; Ton Oude Ophuis; Andrzej Budaj; Pierre Theroux; Mikhail Ruda; Christian Hamm; Shinya Goto; Jindrich Spinar; José Carlos Nicolau; Robert G Kiss; Sabina A Murphy; Stephen D Wiviott; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

5.  ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

Authors:  Stefanie Schulz-Schüpke; Robert A Byrne; Jurrien M Ten Berg; Franz-Josef Neumann; Yaling Han; Tom Adriaenssens; Ralph Tölg; Melchior Seyfarth; Michael Maeng; Bernhard Zrenner; Claudius Jacobshagen; Harald Mudra; Eberhard von Hodenberg; Jochen Wöhrle; Dominick J Angiolillo; Barbara von Merzljak; Nonglag Rifatov; Sebastian Kufner; Tanja Morath; Antonia Feuchtenberger; Tareq Ibrahim; Paul W A Janssen; Christian Valina; Yi Li; Walter Desmet; Mohamed Abdel-Wahab; Klaus Tiroch; Christian Hengstenberg; Isabell Bernlochner; Marcus Fischer; Heribert Schunkert; Karl-Ludwig Laugwitz; Albert Schömig; Julinda Mehilli; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-01-23       Impact factor: 29.983

6.  Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Authors:  Robert W Yeh; Eric A Secemsky; Dean J Kereiakes; Sharon-Lise T Normand; Anthony H Gershlick; David J Cohen; John A Spertus; Philippe Gabriel Steg; Donald E Cutlip; Michael J Rinaldi; Edoardo Camenzind; William Wijns; Patricia K Apruzzese; Yang Song; Joseph M Massaro; Laura Mauri
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

Review 7.  Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  John A Bittl; Usman Baber; Steven M Bradley; Duminda N Wijeysundera
Journal:  J Am Coll Cardiol       Date:  2016-03-29       Impact factor: 24.094

8.  Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

Authors:  Usman Baber; Roxana Mehran; Gennaro Giustino; David J Cohen; Timothy D Henry; Samantha Sartori; Cono Ariti; Claire Litherland; George Dangas; C Michael Gibson; Mitchell W Krucoff; David J Moliterno; Ajay J Kirtane; Gregg W Stone; Antonio Colombo; Alaide Chieffo; Annapoorna S Kini; Bernhard Witzenbichler; Giora Weisz; Philippe Gabriel Steg; Stuart Pocock
Journal:  J Am Coll Cardiol       Date:  2016-04-11       Impact factor: 24.094

Review 9.  Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.

Authors:  Tullio Palmerini; Diego Della Riva; Umberto Benedetto; Letizia Bacchi Reggiani; Fausto Feres; Alexandre Abizaid; Martine Gilard; Marie-Claude Morice; Marco Valgimigli; Myeong-Ki Hong; Byeong-Keuk Kim; Yangsoo Jang; Hyo-Soo Kim; Kyung Woo Park; Antonio Colombo; Alaide Chieffo; Diego Sangiorgi; Giuseppe Biondi-Zoccai; Philippe Généreux; Gianni D Angelini; Maria Pufulete; Jonathon White; Deepak L Bhatt; Gregg W Stone
Journal:  Eur Heart J       Date:  2017-04-07       Impact factor: 29.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.